DelistingJun 16, 2026, 04:27 PM
MaxCyte Regains Nasdaq Minimum Bid Price Compliance
AI Summary
MaxCyte, Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement. The company previously received a notice on March 16, 2026, for failing to maintain a closing bid price of $1.00 or greater for 30 consecutive trading days. Nasdaq confirmed on June 10, 2026, that MaxCyte's common stock maintained a closing bid price of $1.00 or greater for 10 consecutive business days, thereby resolving the issue.
Key Highlights
- MaxCyte previously received a Nasdaq notice on March 16, 2026, for non-compliance with the minimum $1.00 bid price rule.
- The company's common stock closing bid price fell below $1.00 for 30 consecutive trading days.
- On June 10, 2026, Nasdaq confirmed MaxCyte regained compliance.
- The closing bid price was $1.00 or greater for 10 consecutive business days, from May 27 to June 9, 2026.
- The matter regarding the minimum bid price requirement is now closed.
Price Impact
More from MXCT